Moscow accuses OPCW of manipulating Skripal probe

Image
AFP Moscow
Last Updated : Apr 15 2018 | 12:30 AM IST

Don't want to miss the best from Business Standard?

Moscow today accused the chemical weapons watchdog of manipulating the results of its probe into the poisoning of a former Russian spy, saying his samples had traces of a nerve agent used by the West.

Britain says former double agent Sergei Skripal and his daughter Yulia were last month targeted with a nerve agent of the Novichok family which was developed in the Soviet Union.

The attack shredded ties between Russia and Britain and led to a severe crisis in relations between Moscow and the West including a huge wave of tit-for-tat diplomatic expulsions.

The Organisation for the Prohibition of Chemical Weapons has said it confirmed "the findings of the United Kingdom relating to the identity of the toxic chemical" without naming the substance involved.

Today, Russian Foreign Minister Sergei Lavrov said the OPCW had sent the Skripals' biomedical samples to Swiss experts who found they contained traces of the nerve agent BZ used by the West.

"According to the results of the examination, the samples had traces of toxic chemical BZ and its precursors," Lavrov said, citing what he said was "confidential information." "BZ is a nerve agent that temporarily incapacitates a person," Lavrov said, adding that the chemical was used by the military of the US, Britain and other NATO members.

"Russia and the USSR never developed such chemical substances." "In this regard we are asking the OPCW why the information which reflected the conclusions of specialists from the Spiez Laboratory was completely omitted from the final document." "And of course if the OPCW decides to deny that it used the Spiez Laboratory then it would be interesting to hear those explanations too."

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 15 2018 | 12:30 AM IST

Next Story